Neurology

New research shows that opioid-exposed newborns have 5% smaller brain volumes, varying by drug type.

Cognitive phenotyping boosts the accuracy of blood biomarkers in predicting brain amyloidosis in Alzheimer’s diagnosis.

A randomised clinical trial shows that the SMART-CP boosts rehab access for Bangladeshi children with cerebral palsy.

ADHD may increase risk of dementia due to elevated brain iron and neuroaxonal damage in adults.

The TRACK-FA study reveals that stalled spinal cord development in childhood Friedreich ataxia, offering new biomarkers for trials.

The TRANSPORT2 trial finds that tDCS fails to boost poststroke motor recovery, despite safety profile.

Reldesemtiv fails to slow ALS progression in COURAGE-ALS trial, highlighting challenges in ALS treatment development.

Study shows that breastfeeding for at least six months can reduce developmental delays in children.

Donanemab raises ARIA risk in Alzheimer’s, requiring vigilant monitoring.

A new study reveals that APOE ε4 drives Lewy body severity, reshaping LBD genetic understanding.

Discover how sex and genes alter Alzheimer’s risks. Find out why personalised care matters.

High-dose vitamin D delays MS progression by 200 days in early-stage patients. MRI data shows significant benefits.

ITSN1 gene variant raises Parkinson’s risk tenfold, with links to autism. Breakthrough study reveals dual neurological threat.

Groundbreaking research links EBV antibodies to MS via brain protein attacks. Genetic risks amplify danger, paving the way for targeted therapies.

Ultrasound therapy boosts cognition in younger Alzheimer’s patients. Study highlights TPS as a potential add-on treatment.

Parkinson’s disease cases are set to double by 2050 due to ageing populations. Study highlights urgent need for action.

Gut microbiome study identifies microbial ratio linked to multiple sclerosis severity, offering potential for diagnostics and therapies.

Low-dose semaglutide reduces alcohol cravings and some drinking behaviours in adults with alcohol use disorder.

Nasal spray shows promise in treating traumatic brain injury by reducing inflammation and enhancing immune cell function in mouse models.

New 4D brain map unveils early warning signs and potential therapeutic targets for multiple sclerosis, offering hope for improved treatments.

Brain haemorrhages double dementia risk, urging regular cognitive screening for affected patients. New research highlights critical clinical implications.

A clinical trial finds tetramethylpyrazine nitrone safe for ALS, with potential benefits in grip strength for younger patients.

AI-powered MELD Graph detects 64% of epilepsy-causing lesions missed by radiologists, enhancing FCD diagnosis and surgical planning.

New research suggests both low and high vitamin B12 levels impact brain health in older adults, challenging current recommendations.

Teleneurorehabilitation safely improves Parkinson’s symptoms and quality of life, offering a viable alternative to in-person therapy.

Explore how genetic and phenotypic features of psychosis in epilepsy can guide precision medicine.

Pridopidine did not slow ALS progression in a 24-week trial. Findings highlight the need for continued research and alternative therapies.

New research finds adults with depression develop physical illnesses 30% faster. Integrated care approaches are urgently needed.

Stroke survivors with high genetic risk for type 2 diabetes face poorer blood sugar control, new study reveals.

High-frequency oscillations predict seizure risk in Alzheimer’s. Levetiracetam reduces them in epileptic patients but increases them in non-epileptic cases.

Replacing regular salt with a reduced-sodium, added-potassium substitute significantly lowered recurrent stroke and mortality risk in stroke patients.

Delayed REM sleep may indicate early Alzheimer’s, with longer REM latency linked to increased toxic protein levels and reduced neuroprotective factors.